BD's Vince Forlenza Highlights Sequestration Threat To MedTech Research
This article was originally published in The Gray Sheet
Executive Summary
At a Sept. 20 event in Washington, D.C., Becton Dickinson President and CEO Vince Forlenza said biomedical progress would be undermined by sequestration cuts to the National Institutes of Health. Meanwhile, a new poll shows many Americans oppose cutting medical research.